This post is sponsored by Prolaris and Myriad Genetics via Global Influence.

A few years ago, a good friend of my father’s was diagnosed with prostate cancer and sadly passed away just a few months later. I will never forget the sadness that surrounded his passing and how many different people grieved for him. You never realize how much of a role a person plays in your life until they are no longer there… their absents leaves you with a unbearable sadness. My heart hurt even more for my father as I realized he had to go on working and get accustomed to no longer seeing his friend each day at work. This wasn’t the only time in my life where cancer has taken someone away that we loved or cared for and I sadly… I know it won’t be the last. If there is one thing I have learned from so many around me losing the battle is how vital  and important early detection is. Never doubt yourself, always trust your gut or instinct and always… and I mean always, make sure to visit your primary care doctor regularly.

What is Prolaris?

Prolaris is a genetic test for prostate cancer from Myriad Genetics Laboratories that combines traditional risk factors with molecular assessment. Prolaris is the only test that measures how fast prostate cancer cells are dividing. The information obtained from this test greatly impacts the treatment choices that someone diagnosed with Prostate cancer would choose. 
                               

Why Prostate Cancer?

1.2 million biopsies a year lead to 240,000 prostate cancer diagnoses and 30,000 deaths. Prostate cancer is the 2nd leading cause of cancer related death in the United States. Since women tend to take the dominant role in health care and screening in their homes, we want them to be more educated about Prostate cancer and in turn, to educate their loved ones.